VCAM1 and rheumatoid arthritis: On the other hand, patients with RA-ILD+ showed significantly higher serum levels of VCAM-1, MCP-1 and ADMA compared to those with IPF (p < 0.01 in all cases, Figures 1A, C, E, Supplementary Table S1).